Keyphrases
Thrombolytic Therapy
100%
Fibrinolysis
100%
Massive Pulmonary Embolism
100%
Reduced Dose
100%
Right Ventricular Function
75%
Pulmonary Hypertension
75%
Pulmonary Embolism
50%
In-hospital Mortality
50%
Major Complications
50%
Tissue Plasminogen Activator (t-PA)
50%
Effective Therapy
25%
Cohort Trial
25%
Major Bleeding
25%
Consecutive Patients
25%
Left Ventricle
25%
In-hospital Death
25%
In-hospital Outcomes
25%
Single Center
25%
University Hospital
25%
High Mortality Rate
25%
Pulmonary Artery Systolic Pressure
25%
Tricuspid Annular Plane Systolic Excursion (TAPSE)
25%
Life-threatening Bleeding
25%
Major Stroke
25%
Intravenous Infusion
25%
Intravenous Tissue Plasminogen Activator
25%
Safe Therapy
25%
6-month Mortality
25%
Peripheral Intravenous
25%
Extended Infusion
25%
Myocardial Performance Index
25%
Low-dose Administration
25%
Medicine and Dentistry
Pulmonary Embolism
100%
Fibrinolysis
100%
Fibrinolytic Therapy
66%
Pulmonary Hypertension
50%
Tissue Plasminogen Activator
50%
Low Drug Dose
33%
Heart Right Ventricle Function
33%
Hospital Mortality
33%
Systolic Blood Pressure
16%
Apoplexy
16%
Major Bleeding
16%
Right Ventricular Function
16%
Bleeding
16%
Left Ventricle
16%
Infusion
16%
Mortality Rate
16%
Pulmonary Artery
16%
Intravenous Drug Administration
16%
Heart Performance
16%
Nursing and Health Professions
Lung Embolism
100%
Pilot Study
100%
Fibrinolytic Therapy
66%
Tissue Plasminogen Activator
50%
Pulmonary Hypertension
50%
Low Drug Dose
33%
Hospital Mortality
33%
Bleeding
33%
Systolic Blood Pressure
16%
Mortality Rate
16%
University Hospital
16%
Infusion
16%
Cerebrovascular Accident
16%
Intravenous Drug Administration
16%
Tricuspid Annular Plane Systolic Excursion
16%
Efficacy
16%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Embolism
100%
Fibrinolytic Agent
66%
Tissue Plasminogen Activator
50%
Pulmonary Hypertension
50%
Bleeding
33%
Hospital Mortality
33%
Mortality Rate
16%
Cerebrovascular Accident
16%